“We are encouraged by the emerging data from our lung cancer programs, where systemically delivered Olvi-Vec continues to ...

New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society of Nuclear Medicine and Molecular Imaging, an international scientific and ...

Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...

The BioMarin Pharmaceutical Inc. acquisition of Amicus Therapeutics, Inc. will likely be beneficial and accretive for both ...

Plymouth Meeting, Pennsylvania Tuesday, December 30, 2025, 15:00 Hrs [IST] ...

Explore the challenges faced by Indian pharma in developing rare disease drugs and potential solutions for innovation and cost reduction.

From respiratory infection to fatal neurological disease, EHV-1 demands rapid PCR diagnosis, and detection protocols impact ...

G aims to bring the power of satellite communication to your pocket. In A Nutshell Major obstacles include managing handoffs ...

Issued on behalf of Oncolytics Biotech Inc.USANewsGroup.com News CommentaryVANCOUVER, BC, Dec. 31, 2025 /PRNewswire/ -- The precision oncology market ...

This exploratory study in healthy young adults found that plasma sodium levels within the normal clinical range are ...

Oncology and tackling chronic issues like obesity are still the big drivers for growth in the biotech world. Combining ...